title: Discussion of the paper "Adaptive dose-ranging designs".
authors.affiliation: Biostatistics, AstraZeneca R&D, Mölndal, Sweden. carl-fredrik.burman@astrazeneca.com
authors.forename: Carl-Fredrik
authors.initials: CF
authors.lastname: Burman
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D006801:Humans; D012107:Research Design